1 Market Overview
1.1 Antibiotic Resistance Introduction
1.2 Market Analysis by Type
1.2.1 Urinary Tract Infection
1.2.2 Intra-Abdominal Infections
1.2.3 Blood Stream Infections
1.2.4 Clostridium Difficile Infections
1.2.5 Acute Bacterial Skin and Skin Structure Infections
1.2.6 Bacterial Pneumonia
1.3 Market Analysis by Applications
1.3.1 Oxazolidinones
1.3.2 Lipoglycopeptides
1.3.3 Tetracyclines
1.3.4 Cephalosporins
1.3.5 Combination therapies
1.3.6 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2015-2025)
1.4.1.2 Canada Market States and Outlook (2015-2025)
1.4.1.3 Mexico Market States and Outlook (2015-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2015-2025)
1.4.2.2 France Market States and Outlook (2015-2025)
1.4.2.3 UK Market States and Outlook (2015-2025)
1.4.2.4 Russia Market States and Outlook (2015-2025)
1.4.2.5 Italy Market States and Outlook (2015-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2015-2025)
1.4.3.2 Japan Market States and Outlook (2015-2025)
1.4.3.3 Korea Market States and Outlook (2015-2025)
1.4.3.4 India Market States and Outlook (2015-2025)
1.4.3.5 Southeast Asia Market States and Outlook (2015-2025)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2015-2025)
1.4.4.2 Egypt Market States and Outlook (2015-2025)
1.4.4.3 Saudi Arabia Market States and Outlook (2015-2025)
1.4.4.4 South Africa Market States and Outlook (2015-2025)
1.4.4.5 Turkey Market States and Outlook (2015-2025)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Business Overview
2.1.2 Antibiotic Resistance Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.2 AmpliPhi Biosciences
2.2.1 Business Overview
2.2.2 Antibiotic Resistance Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AmpliPhi Biosciences Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.3 BioVersys GmbH
2.3.1 Business Overview
2.3.2 Antibiotic Resistance Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BioVersys GmbH Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.4 Macrolide Pharmaceuticals
2.4.1 Business Overview
2.4.2 Antibiotic Resistance Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Macrolide Pharmaceuticals Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.5 Melinta Therapeutics
2.5.1 Business Overview
2.5.2 Antibiotic Resistance Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Melinta Therapeutics Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.6 Merck
2.6.1 Business Overview
2.6.2 Antibiotic Resistance Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Merck Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.7 Nabriva Therapeutics
2.7.1 Business Overview
2.7.2 Antibiotic Resistance Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Nabriva Therapeutics Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.8 Nemesis Bioscience
2.8.1 Business Overview
2.8.2 Antibiotic Resistance Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Nemesis Bioscience Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.9 Phage Technologies S.A
2.9.1 Business Overview
2.9.2 Antibiotic Resistance Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Phage Technologies S.A Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.10 Tetraphase Pharmaceuticals
2.10.1 Business Overview
2.10.2 Antibiotic Resistance Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.11 The Medicines Company
2.11.1 Business Overview
2.11.2 Antibiotic Resistance Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 The Medicines Company Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.12 TPfizer
2.12.1 Business Overview
2.12.2 Antibiotic Resistance Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 TPfizer Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
2.13 Westway Health
2.13.1 Business Overview
2.13.2 Antibiotic Resistance Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Westway Health Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2019)
3 Global Antibiotic Resistance Sales, Revenue, Market Share and Competition by Manufacturer (2017-2019)
3.1 Global Antibiotic Resistance Sales and Market Share by Manufacturer (2017-2019)
3.2 Global Antibiotic Resistance Revenue and Market Share by Manufacturer (2017-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Antibiotic Resistance Manufacturer Market Share in 2019
3.3.2 Top 6 Antibiotic Resistance Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Antibiotic Resistance Market Analysis by Regions
4.1 Global Antibiotic Resistance Sales, Revenue and Market Share by Regions
4.1.1 Global Antibiotic Resistance Sales and Market Share by Regions (2015-2019)
4.1.2 Global Antibiotic Resistance Revenue and Market Share by Regions (2015-2019)
4.2 North America Antibiotic Resistance Sales and Growth Rate (2015-2019)
4.3 Europe Antibiotic Resistance Sales and Growth Rate (2015-2019)
4.4 Asia-Pacific Antibiotic Resistance Sales and Growth Rate (2015-2019)
4.5 South America Antibiotic Resistance Sales and Growth Rate (2015-2019)
4.6 Middle East and Africa Antibiotic Resistance Sales and Growth Rate (2015-2019)
5 North America Antibiotic Resistance by Country
5.1 North America Antibiotic Resistance Sales, Revenue and Market Share by Country
5.1.1 North America Antibiotic Resistance Sales and Market Share by Country (2015-2019)
5.1.2 North America Antibiotic Resistance Revenue and Market Share by Country (2015-2019)
5.2 United States Antibiotic Resistance Sales and Growth Rate (2015-2019)
5.3 Canada Antibiotic Resistance Sales and Growth Rate (2015-2019)
5.4 Mexico Antibiotic Resistance Sales and Growth Rate (2015-2019)
6 Europe Antibiotic Resistance by Country
6.1 Europe Antibiotic Resistance Sales, Revenue and Market Share by Country
6.1.1 Europe Antibiotic Resistance Sales and Market Share by Country (2015-2019)
6.1.2 Europe Antibiotic Resistance Revenue and Market Share by Country (2015-2019)
6.2 Germany Antibiotic Resistance Sales and Growth Rate (2015-2019)
6.3 UK Antibiotic Resistance Sales and Growth Rate (2015-2019)
6.4 France Antibiotic Resistance Sales and Growth Rate (2015-2019)
6.5 Russia Antibiotic Resistance Sales and Growth Rate (2015-2019)
6.6 Italy Antibiotic Resistance Sales and Growth Rate (2015-2019)
7 Asia-Pacific Antibiotic Resistance by Country
7.1 Asia-Pacific Antibiotic Resistance Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Antibiotic Resistance Sales and Market Share by Country (2015-2019)
7.1.2 Asia-Pacific Antibiotic Resistance Revenue and Market Share by Country (2015-2019)
7.2 China Antibiotic Resistance Sales and Growth Rate (2015-2019)
7.3 Japan Antibiotic Resistance Sales and Growth Rate (2015-2019)
7.4 Korea Antibiotic Resistance Sales and Growth Rate (2015-2019)
7.5 India Antibiotic Resistance Sales and Growth Rate (2015-2019)
7.6 Southeast Asia Antibiotic Resistance Sales and Growth Rate (2015-2019)
8 South America Antibiotic Resistance by Country
8.1 South America Antibiotic Resistance Sales, Revenue and Market Share by Country
8.1.1 South America Antibiotic Resistance Sales and Market Share by Country (2015-2019)
8.1.2 South America Antibiotic Resistance Revenue and Market Share by Country (2015-2019)
8.2 Brazil Antibiotic Resistance Sales and Growth Rate (2015-2019)
8.3 Argentina Antibiotic Resistance Sales and Growth Rate (2015-2019)
8.4 Colombia Antibiotic Resistance Sales and Growth Rate (2015-2019)
9 Middle East and Africa Antibiotic Resistance by Countries
9.1 Middle East and Africa Antibiotic Resistance Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Antibiotic Resistance Sales and Market Share by Country (2015-2019)
9.1.2 Middle East and Africa Antibiotic Resistance Revenue and Market Share by Country (2015-2019)
9.2 Saudi Arabia Antibiotic Resistance Sales and Growth Rate (2015-2019)
9.3 Turkey Antibiotic Resistance Sales and Growth Rate (2015-2019)
9.4 Egypt Antibiotic Resistance Sales and Growth Rate (2015-2019)
9.5 Nigeria Antibiotic Resistance Sales and Growth Rate (2015-2019)
9.6 South Africa Antibiotic Resistance Sales and Growth Rate (2015-2019)
10 Global Antibiotic Resistance Market Segment by Type
10.1 Global Antibiotic Resistance Sales, Revenue and Market Share by Type (2015-2019)
10.1.1 Global Antibiotic Resistance Sales and Market Share by Type (2015-2019)
10.1.2 Global Antibiotic Resistance Revenue and Market Share by Type (2015-2019)
10.2 Urinary Tract Infection Sales Growth and Price
10.2.1 Global Urinary Tract Infection Sales Growth (2015-2019)
10.2.2 Global Urinary Tract Infection Price (2015-2019)
10.3 Intra-Abdominal Infections Sales Growth and Price
10.3.1 Global Intra-Abdominal Infections Sales Growth (2015-2019)
10.3.2 Global Intra-Abdominal Infections Price (2015-2019)
10.4 Blood Stream Infections Sales Growth and Price
10.4.1 Global Blood Stream Infections Sales Growth (2015-2019)
10.4.2 Global Blood Stream Infections Price (2015-2019)
10.5 Clostridium Difficile Infections Sales Growth and Price
10.5.1 Global Clostridium Difficile Infections Sales Growth (2015-2019)
10.5.2 Global Clostridium Difficile Infections Price (2015-2019)
10.6 Acute Bacterial Skin and Skin Structure Infections Sales Growth and Price
10.6.1 Global Acute Bacterial Skin and Skin Structure Infections Sales Growth (2015-2019)
10.6.2 Global Acute Bacterial Skin and Skin Structure Infections Price (2015-2019)
10.7 Bacterial Pneumonia Sales Growth and Price
10.7.1 Global Bacterial Pneumonia Sales Growth (2015-2019)
10.7.2 Global Bacterial Pneumonia Price (2015-2019)
11 Global Antibiotic Resistance Market Segment by Application
11.1 Global Antibiotic Resistance Sales Market Share by Application (2015-2019)
11.2 Oxazolidinones Sales Growth (2015-2019)
11.3 Lipoglycopeptides Sales Growth (2015-2019)
11.4 Tetracyclines Sales Growth (2015-2019)
11.5 Cephalosporins Sales Growth (2015-2019)
11.6 Combination therapies Sales Growth (2015-2019)
11.7 Other Sales Growth (2015-2019)
12 Antibiotic Resistance Market Forecast (2020-2025)
12.1 Global Antibiotic Resistance Sales, Revenue and Growth Rate (2020-2025)
12.2 Antibiotic Resistance Market Forecast by Regions (2020-2025)
12.2.1 North America Antibiotic Resistance Market Forecast (2020-2025)
12.2.2 Europe Antibiotic Resistance Market Forecast (2020-2025)
12.2.3 Asia-Pacific Antibiotic Resistance Market Forecast (2020-2025)
12.2.4 South America Antibiotic Resistance Market Forecast (2020-2025)
12.2.5 Middle East and Africa Antibiotic Resistance Market Forecast (2020-2025)
12.3 Antibiotic Resistance Market Forecast by Type (2020-2025)
12.3.1 Global Antibiotic Resistance Sales Forecast by Type (2020-2025)
12.3.2 Global Antibiotic Resistance Market Share Forecast by Type (2020-2025)
12.4 Antibiotic Resistance Market Forecast by Application (2020-2025)
12.4.1 Global Antibiotic Resistance Sales Forecast by Application (2020-2025)
12.4.2 Global Antibiotic Resistance Market Share Forecast by Application (2020-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
